First-trimester screening for down syndrome using nuchal translucency measurement with free β-hCG and PAPP-A between 10 and 13 weeks of pregnancy - The combined test

Prenatal Diagnosis

Volumn 19, Issue 4, 1999, Pages 360-363

  De Biasio, P ^a   Siccardi, M ^a   Volpe, G ^a   Famularo, L ^a   Santi, F ^a   Canini, S ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Fetal nuchal translucency; Free hCG; Pregnancy associated plasma protein A; Prenatal screening

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CLINICAL TRIAL; CROWN RUMP LENGTH; DEVICE; DIAGNOSTIC TEST; DOWN SYNDROME; FEMALE; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; IMMUNORADIOMETRIC ASSAY; MATERNAL AGE; MATERNAL BLOOD; MULTIVARIATE ANALYSIS; NECK MUSCLE; NORMAL HUMAN; PRENATAL SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; ULTRASOUND PROBE;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; MATERNAL AGE; NECK; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 0032915259     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199904)19:4<360::AID-PD556>3.0.CO;2-U     Document Type: Article

References (8)

1. Bewley S, Roberts LJ, Meckinson A-M, Rodeck CH. 1995. First trimester fetal nuchal translucency: problems with screening the general population 2. Br J Obstet Gynaecol 102: 386-388.
2. Firth HV, Boyd PA, Chamberlain PF, Mackenze IZ, Harris-Kay GH, Huson SM. 1994. Analysis of limb reduction defects in babies exposed to chorionic villus sampling. Lancet 343: 1069-1071.
3. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. 1992. Fetal nuchal translucency: ultrasound screening for chromosomal effects in first trimester of pregnancy. Br Med J 304: 867-869.
4. Olney RTS, Khoury MJ, Botto LD, Mastroiacovo P. 1994. Limb defects and gestational age at chorionic villus sampling. Lancet 344: 476.
5. Roberts LJ, Bewley S, Meckinson A-M, Rodeck CH. 1995. First trimester fetal nuchal translucency: problems with screening for general population 1. Br J Obstet Gynaecol 102: 381-385.
6. Wald NJ, George L, Smith D, Densem JW, Petterson K. 1996. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 103: 407-412.
7. Wald NJ, Hackshaw AK. 1997. Combined ultrasound and biochemistry in first trimester screening for Down's syndrome. Prenat Diagn 17: 821-829.
8. Wald NJ, Kennard A, Hackshaw A, McGuine A. 1997. Antenatal screening for Down syndrome. J Med Screen 4: 181-246.